Literature DB >> 1689193

Cytotoxic lymphocytes in B-cell chronic lymphocytic leukemia. A flow cytometric study of peripheral blood, lymph nodes and bone marrow.

L W Terstappen1, B G de Grooth, I Segers-Nolten, J Greve.   

Abstract

The occurrence of cytotoxic lymphocyte subpopulations (i.e., CD 16+, CD 57+ and cytotoxic CD 8+) wa studied in the peripheral blood of 18 B-cell chronic lymphocytic leukemia (B-CLL) patients. The absolute numbers of CD 57+, CD 16+ and cytotoxic CD 8+ lymphocytes were increased in the peripheral blood of untreated patients as compared with healthy donors, suggesting a causal relation with the accumulation of malignant B-cells. For 5 B-CLL patients and 5 hematological normal donors, the lymphocyte subpopulations in peripheral blood, lymph nodes and bone marrow were determined. A significant immune response was observed in the lymph nodes of the patients, as reflected by the CD 3+ lymphocytes, which were 1.7-27 times larger in the patients lymph nodes than in their peripheral blood and bone marrow. In contrast, with peripheral blood this was mainly caused by an increase in CD 4+ lymphocytes. The CD 57 lymphocytes in the lymph nodes of the patients had abnormal orthogonal light-scattering signals and an abnormal density of CD 57+ receptors in comparison with their peripheral blood CD 57+ lymphocytes or the CD 57+ lymphocytes in the peripheral blood, bone marrow and tonsils of the hematological normal donors. This study shows that although a significant increase of cytotoxic lymphocytes in the peripheral blood of B-CLL patients is observed, the actual distributions of the non-malignant lymphocytes can be quite different at the actual tumor sites, i.e., bone marrow and lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689193     DOI: 10.1007/bf01720512

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  26 in total

1.  T cells in B cell chronic lymphocytic leukaemia. I. Decreased frequency of T lymphocytes secreting suppressor factor.

Authors:  A C Bloem; J C Clevers; E J Bast; R E Ballieux
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

2.  Reduced natural killer T-cells in B-cell chronic lymphocytic leukaemia identified by three monoclonal antibodies: Leu-11, A10, AB8.28.

Authors:  R Foa; M T Fierro; P Lusso; D Raspadori; M L Ferrando; L Matera; F Malavasi; F Lauria
Journal:  Br J Haematol       Date:  1986-01       Impact factor: 6.998

3.  Suppressor T cells in B-cell chronic lymphocytic leukaemia: relationship to clinical stage.

Authors:  K H Mills; J C Cawley
Journal:  Leuk Res       Date:  1982       Impact factor: 3.156

4.  Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies.

Authors:  C D Platsoucas; M Galinski; S Kempin; L Reich; B Clarkson; R A Good
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

5.  Characterization of the phytohemagglutinin-induced proliferating lymphocyte subpopulations in chronic lymphocytic leukemia patients using a clonogenic agar technique and monoclonal antibodies.

Authors:  S Davis
Journal:  Blood       Date:  1981-11       Impact factor: 22.113

6.  Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia.

Authors:  D Catovsky; F Lauria; E Matutes; R Foa; V Mantovani; S Tura; D A Galton
Journal:  Br J Haematol       Date:  1981-04       Impact factor: 6.998

7.  Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell type.

Authors:  F Herrmann; A Lochner; H Philippen; B Jauer; H Rühl
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

8.  T cell helper defect in patients with chronic lymphocytic leukemia.

Authors:  N Chiorazzi; S M Fu; G Montazeri; H G Kunkel; K Rai; T Gee
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

9.  Expression of NK-lineage markers on peripheral blood lymphocytes with T-helper (Leu3+/T4+) phenotype in B cell chronic lymphocytic leukemia.

Authors:  A Velardi; J T Prchal; E F Prasthofer; C E Grossi
Journal:  Blood       Date:  1985-01       Impact factor: 22.113

10.  Lack of autologous mixed lymphocyte reaction in patients with chronic lymphocytic leukemia: evidence for autoreactive T-cell dysfunction not correlated with phenotype, karyotype, or clinical status.

Authors:  T Han; M L Bloom; B Dadey; G Bennett; J Minowada; A A Sandberg; H Ozer
Journal:  Blood       Date:  1982-11       Impact factor: 22.113

View more
  1 in total

1.  Immune and hormonal changes in early-stage chronic lymphocytic leukemia patients.

Authors:  H Everaus; J Lehtmaa; E Luik; H Kŏdar
Journal:  Ann Hematol       Date:  1992-11       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.